抗生素审查工具包(ARK)干预方案的制定:一项旨在安全审查和减少急性与普通内科抗生素处方的数字与行为干预
本研究采用基于理论、证据和人的方法,通过迭代利益相关者咨询和深度定性研究,开发并优化了抗生素审查工具包(ARK)干预。关键障碍是缺乏关于初始处方者理由和确定性的信息,因此开发了决策辅助工具以增加透明度。ARK将在可行性研究和阶梯楔形整群随机对照试验中评估。
要点
- ARK是一种支持「审查与修订」的数字、组织与行为干预,旨在安全停用不必要抗生素。
- 停用抗生素的关键障碍是缺乏初始处方者理由和确定性的信息。
- 决策辅助工具是ARK的核心组成部分,用于增加初始处方决策的透明度。
核心结论
- ARK是一种针对审查时停用抗生素重要障碍的数字与行为干预,将在可行性研究和阶梯楔形整群随机对照试验中评估。
研究设计与样本
- 采用基于理论、证据和人的方法,通过迭代利益相关者咨询和深度定性研究,与英国医院的医生、护士和药师共同开发并优化ARK干预。
主要发现
- 停用抗生素的关键障碍是缺乏关于初始处方者理由及其对需要抗生素的确定程度的信息。
- ARK的核心组成部分是开发并优化决策辅助工具及其实现,以增加初始处方决策的透明度。
临床怎么用
- ARK可用于支持医疗专业人员在审查时安全停用不必要的抗生素,通过决策辅助工具增加初始处方决策的透明度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hospital antimicrobial stewardship strategies, such as 'Start Smart, Then Focus' in the UK, balance the need for prompt, effective antibiotic treatment with the need to limit antibiotic overuse using 'review and revise'. However, only a minority of review decisions are to stop antibiotics. Research suggests that this is due to both behavioural and organizational factors. OBJECTIVES: To develop and optimize the Antibiotic Review Kit (ARK) intervention. ARK is a complex digital, organizational and behavioural intervention that supports implementation of 'review and revise' to help healthcare professionals safely stop unnecessary antibiotics. METHODS: A theory-, evidence- and person-based approach was used to develop and optimize ARK and its implementation. This was done through iterative stakeholder consultation and in-depth qualitative research with doctors, nurses and pharmacists in UK hospitals. Barriers to and facilitators of the intervention and its implementation, and ways to address them, were identified and then used to inform the intervention's development. RESULTS: A key barrier to stopping antibiotics was reportedly a lack of information about the original prescriber's rationale for and their degree of certainty about the need for antibiotics. An integral component of ARK was the development and optimization of a Decision Aid and its implementation to increase transparency around initial prescribing decisions. CONCLUSIONS: The key output of this research is a digital and behavioural intervention targeting important barriers to stopping antibiotics at review (see http://bsac-vle.com/ark-the-antibiotic-review-kit/ and http://antibioticreviewkit.org.uk/). ARK will be evaluated in a feasibility study and, if successful, a stepped-wedge cluster-randomized controlled trial at acute hospitals across the NHS.
引用
- Santillo M, Sivyer K, Krusche A, et al. Intervention planning for Antibiotic Review Kit (ARK): a digital and behavioural intervention to safely review and reduce antibiotic prescriptions in acute and general medicine. J Antimicrob Chemother. 2019. PMID: 31430366. doi:10.1093/jac/dkz333
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。